Delivery Order SPE2DB22D3009-SPE2DB25FBF02
Award Date 9/14/25
Potential Completion Date 9/15/25
Potential Value $1.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for IPOL vials (5mL) valued at $5,450.50 under a firm fixed price contract type. This non-set-aside award, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a standard medical supply delivery to support federal healthcare operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of IPOL Vial 5ML, a poliomyelitis vaccine product. This firm fixed-price delivery order, valued at $1,526.14, represents a non-competitive award and is categorized as a child contract under AmerisourceBergen's larger federal contract vehicle. The order is scheduled for completion by August 19, 2025, with performance at the contractor's location in Conshohocken,...
- The Defense Logistics Agency Troop Support Medical awarded a $273,510 firm fixed price delivery order to Amerisourcebergen Drug Corporation for IPOL vials. The order is for 4561322355 5mL vials of IPOL to be delivered to Amerisourcebergen's facility in Conshohocken, Pennsylvania by June 26, 2023. Amerisourcebergen will provide the vials in support of the Defense Logistics Agency's medical supply chain initiatives. No subcontractors or set aside designations were identified. The delivery order...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of IPOL VIAL 5ML medical products. The $1,796.20 contract has an ultimate completion date of August 23, 2022. Amerisourcebergen Drug Corp, through its Corporate Office Division, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
- The U.S. Department of Defense awarded a $59,335.20 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a completion date of October 2, 2023, is for the delivery of 4562356439 IPOL VIAL 5ML medical supplies. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the Defense Logistics Agency (DLA) Troop Support Medical, which provides a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $12,645.16, is for the delivery of IPOL VIAL 5ML pharmaceutical products. It is a firm fixed-price contract with a period of performance through May 1, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $43,892.31 and covers the delivery of IPOL VIAL 5ML medical products. The contract has an ultimate completion date of February 28, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,149.56 firm fixed-price delivery order is for the supply of IPOL VIAL 5ML medical products, with a period of performance through May 23, 2025. The contract is not set aside and represents an open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,668.52 firm fixed-price delivery order is for the supply of 4567951715 IPOL VIAL 5ML, with a performance period ending on April 18, 2025. The contract is not set aside and is considered an open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $12,808.20 firm fixed price contract is for the supply of IPOL VIAL 5ML, a pharmaceutical product, with a completion date of November 13, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...